E-LIB Suche - Ergebnisse für: Legg, J.

1

First report of the severe Uganda variant of East African c..:

Tembo, M. ; Crespo‐Bellido, A. ; Chikoti, P. C....
New Disease Reports. 49 (2024) 1 - p. , 2024

Link: https://doi.org/10.1002/..

2

P454 Body composition and peripheral muscle function in peo..:

Clayton, L. ; Shepherd, A. ; Corbett, J....
Journal of Cystic Fibrosis. 23 (2024) - p. S206 , 2024

Link: https://doi.org/10.1016/..

3

EPS3.01 A comparison of routine cough swabs vs a novel sput..:

Meredith, T. ; Connett, G. ; Legg, J...
Journal of Cystic Fibrosis. 23 (2024) - p. S40-S41 , 2024

Link: https://doi.org/10.1016/..

4

P015 Innovating CF diagnosis in resource-limited settings: ..:

Suresh Shinde, S. ; Pawar, R. ; Peiris, D....
Journal of Cystic Fibrosis. 23 (2024) - p. S71 , 2024

Link: https://doi.org/10.1016/..

5

WS11.01 The use of salivary chloride levels as a screening ..:

Shinde, S. Suresh ; Peiris, D. ; Larcombe, T....
Journal of Cystic Fibrosis. 23 (2024) - p. S20 , 2024

Link: https://doi.org/10.1016/..

6

P460 Assessing the exercise capacity of adolescents with cy..:

Larcombe, T. ; Legg, J. ; Meredith, T..
Journal of Cystic Fibrosis. 23 (2024) - p. S208 , 2024

Link: https://doi.org/10.1016/..

7

EPS7.06 Cardiovascular function in people with cystic fibro..:

Clayton, L. ; Shepherd, A. ; Corbett, J....
Journal of Cystic Fibrosis. 23 (2024) - p. S54-S55 , 2024

Link: https://doi.org/10.1016/..

8

EPS5.08 Elexacaftor/tezacaftor/ ivacaftor reduces need for ..:

Scanlan, N. ; Muthukumarana, T. ; Shinde, S....
Journal of Cystic Fibrosis. 22 (2023) - p. S51 , 2023

Link: https://doi.org/10.1016/..

9

P196 Use of nose clips for routine spirometry helps maximis..:

Larcombe, T. ; Connett, G. ; Legg, J.
Journal of Cystic Fibrosis. 22 (2023) - p. S125 , 2023

Link: https://doi.org/10.1016/..

10

P120 Adherence to elexacaftor/texacaftor/ivacaftor during t..:

Bevan, A. ; Legg, J. ; Connett, G.
Journal of Cystic Fibrosis. 22 (2023) - p. S100-S101 , 2023

Link: https://doi.org/10.1016/..

11

P118 Real-world impact of elexacaftor/tezacaftor/ivacaftor ..:

Thia, L.P. ; Thursfield, R. ; Lee, T....
Journal of Cystic Fibrosis. 22 (2023) - p. S100 , 2023

Link: https://doi.org/10.1016/..

12

P158 Elexacaftor, tezacaftor, ivacaftor (ETI) improves lung..:

Larcombe, T. ; Shinde, S. ; Muthukumarana, T....
Journal of Cystic Fibrosis. 22 (2023) - p. S113 , 2023

Link: https://doi.org/10.1016/..

13

P513: CPX-351 TREATMENT FOR ACUTE MYELOID LEUKEMIA IN ENGLA..:

Legg, A. ; Muzwidzwa, R. ; Lambova, A....
HemaSphere. 6 (2022) - p. 412-413 , 2022

Link: https://doi.org/10.1097/..

14

170 Long-term safety and efficacy of elexacaftor/tezacaftor..:

Griese, M. ; Tullis, E. ; Chilvers, M....
Journal of Cystic Fibrosis. 21 (2022) - p. S99-S100 , 2022

Link: https://doi.org/10.1016/..

15

WS03.05 Percentage days covered: what does it tell us about..:

Bevan, A. ; Legg, J. ; Connett, G.
Journal of Cystic Fibrosis. 21 (2022) - p. S6-S7 , 2022

Link: https://doi.org/10.1016/..